Sarepta Therapeutics
Focused on the development of precision genetic medicines to treat rare neuromuscular
and central nervous system diseases
investorrelations.sarepta.com/?_ga=2.49566691.415372990.1745780982-1018978192.1745780982
Major leader in treatment
- Duchenne muscular dystrophy (Duchenne) and limb-girdle muscular dystrophies (LGMDs)
- Explore perespective produts in Gene therapy and editing
Fundamentals:
- Growing Revenue and EPS
- Trading at historical low PE
- Far below market consensus $148
Technicals
- Near low 200VWAP extension 30% discount
Focused on the development of precision genetic medicines to treat rare neuromuscular
and central nervous system diseases
investorrelations.sarepta.com/?_ga=2.49566691.415372990.1745780982-1018978192.1745780982
Major leader in treatment
- Duchenne muscular dystrophy (Duchenne) and limb-girdle muscular dystrophies (LGMDs)
- Explore perespective produts in Gene therapy and editing
Fundamentals:
- Growing Revenue and EPS
- Trading at historical low PE
- Far below market consensus $148
Technicals
- Near low 200VWAP extension 30% discount
Trade closed: stop reached
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.